Manufactures phase-transfer catalysts, structure-directing agents, electrolyte salts, pharma/agro chemicals.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 8 | 20 | 22 | 22 | 23 | 23 | 23 | 23 |
| Reserves | 110 | 146 | 451 | 493 | 714 | 715 | 731 | 758 |
| Borrowings | 91 | 90 | 120 | 170 | 14 | 36 | 83 | 120 |
| Other Liabilities | 41 | 59 | 65 | 74 | 67 | 61 | 70 | 102 |
| Total Liabilities | 249 | 315 | 658 | 759 | 819 | 836 | 908 | 1.0k |
| AssetsFixed Assets | 111 | 120 | 160 | 196 | 427 | 526 | 515 | 611 |
| CWIP | 5 | 10 | 51 | 231 | 77 | 27 | 80 | 23 |
| Investments | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 4 |
| Other Assets | 133 | 185 | 447 | 332 | 305 | 283 | 312 | 365 |
| Total Assets | 249 | 315 | 658 | 759 | 819 | 836 | 908 | 1.0k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 7 | 25 | 20 | 20 | 28 | 98 | 25 | 31 |
| Cash from Investing | -17 | -40 | -21 | -197 | -101 | -121 | -65 | -116 |
| Cash from Financing | 17 | 10 | -5 | 235 | 38 | 31 | 17 | 79 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -2 | -23 | -1 | -69 | -175 | -30 | -51 | -82 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
TATVA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.